Butterfly Network, Inc.

Butterfly Network, Inc. is a digital health company focused on transforming medical imaging through its proprietary Ultrasound-on-Chip™ semiconductor technology, programmable cloud software, and artificial intelligence. The company's mission is to democratize healthcare by making high-quality ultrasound imaging affordable, easy-to-use, globally accessible, and intelligently connected for everyone around the world. Headquartered in Burlington, Massachusetts, Butterfly Network aims to address the global lack of access to medical imaging.

Butterfly Network's core offerings include its handheld, single-probe, whole-body ultrasound systems: the Butterfly iQ, iQ+, and the third-generation iQ3, which boasts enhanced processing power and clearer images. These devices are complemented by cloud-connected software solutions like Compass AI™ for ultrasound program management, and specialized products such as Butterfly Move (a POCUS cart) and iQ+ Bladder. The company also fosters a developer ecosystem, Butterfly Garden, and is expanding into home and community care.

In recent news, Joseph DeVivo serves as President, CEO, and Chairman, with Dr. Arun Nagdev appointed Chief Medical Officer – POCUS in April 2026. The company reported strong Q1 2026 financial results, with revenue reaching $26.5 million, a 25% year-over-year increase, and reaffirmed its FY 2026 revenue guidance of $117M–$121M. Butterfly Network also secured FDA clearance for its Gestational Age blind-sweep AI tool in March 2026, further solidifying its position as it evolves from a medical device company to an AI-native imaging and semiconductor-based enterprise.